Sponsor Pipeline

Adicet Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06480565 A Phase 1/2 Trial of ADI-270 in ccRCC Clear Cell Renal Cell Carcinoma Active, Not Recruiting
Phase 1
NCT07100873 A Phase 1 Study of ADI-001 in Rheumatoid Arthritis Rheumatoid Arthritis (RA) Recruiting
NCT06375993 A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune… Lupus Nephritis Enrolling by Invitation
Not specified
NCT04911478 Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells Lymphoma, Follicular Active, Not Recruiting
Disease Areas
Get alerts when Adicet Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free